In addition, elevated AKR1B10 expression was associated with shorter PFI in GBM, SKCM, STAD, PAAD, KIRC, KIRP, TGCT, and BRCA, as well as decreased DFI in ACC, STAD, LIHC, BLCA, and TGCT. This evidence concerns the gene AKR1B10 and glioblastoma.